EXtension of Tablo TrEatmeNt Duration Registry (XTEND)

Outset Medical

Status: Completed

Conditions: Acute Kidney Injury; End Stage Renal Disease on Dialysis; End Stage Renal Disease (ESRD)

Treatments: Device: Tablo Hemodialysis System

Study type: Observational

Funder types: Industry

Identifiers

NCT04912050

2020-03

Details and patient eligibility

About

Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy > 12 hours.

Enrollment: 33 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant weighs ≥ 34kg.
• Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or Acute Kidney Injury and is prescribed renal replacement therapy > 12 hours.

Exclusion criteria

• Any documented condition that the Physician feels would prevent the participant from successful inclusion in the study.

Trial design

33 participants in 1 patient group

Tablo Hemodialysis System

Description:

Hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours on the Tablo Hemodialysis System

Treatment:

Device: Tablo Hemodialysis System